Going Concern (Details Narrative) - USD ($)	3 Months Ended			12 Months Ended	110 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Sep. 30, 2015	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Non-cash gain upon deconsolidation ofEntest Biomedical, Inc.					$ 41,645,688
Net Losses					31,277,641
Equity in Net Losses of Entest Biomedical, Inc.					$ 663,649
Net borrowings				$ 116,861
Issuance of convetible debt by Regen Biopharma Inc.; Value		$ 90,000	$ 775,000
Stock issued during period, shares	333,333
Stock issued during period, value	$ 50,000